COCA Now Messages
COCA provides subscribers information on current health issues and emerging threats. Designed to be timely and concise, the COCA Now email message will inform clinicians of new CDC resources and guidance related to emergency preparedness and response. COCA Now emails will be sent as soon as possible after CDC publishes new content, ensuring clinicians are kept up to date.
2022 COCA Now Messages
- COCA Now: September 19, 2022: Recommendations to Prevent Occupationally-acquired Monkeypox Infection in Healthcare Personnel
- COCA Now: August 30, 2022: Clinical Considerations for Dengue Virus Infection
- COCA Now: August 10, 2022: FDA Authorizes Emergency Use of Monkeypox JYNNEOS Vaccine
- COCA Now: July 27, 2022: Clinical Considerations for Monkeypox in Children and Adolescents
- COCA Now: July 22, 2022: New Streamlined Process to Provide Tecovirimat (TPOXX) for Treatment of Monkeypox
- COCA Now: July 19, 2022: Steps for Clinicians to Order Medication to Treat Monkeypox
- COCA Now: July 18, 2022: Sonic Healthcare USA Begins Monkeypox Testing, Increasing Nationwide Testing Capacity
- COCA Now: July 14, 2022: Quest Diagnostics Begins Monkeypox Testing, Increasing Nationwide Testing Capacity
- COCA Now: July 14, 2022: Aegis Sciences Begins Monkeypox Testing
- COCA Now: July 12, 2022: Mayo Clinic Laboratories Begins Monkeypox Testing
- COCA Now: July 6, 2022: Labcorp Begins Monkeypox Testing Today, Doubling Nationwide Testing Capacity
- COCA Now: July 5, 2022: CDC Recommends Moderna COVID-19 Vaccine (Spikevax) for Children and Adolescents Ages 6 through 17 Years
- COCA Now: April 4, 2022: New COVID-19 Test to Treat Initiative and Locator Tool
- COCA Now: March 25, 2022: New CDC COVID-19 Quarantine and Isolation (Q&I) Calculator
- COCA Now: February 24, 2022: Updated List of High-Risk Medical Conditions for Severe COVID-19 Outcomes
- COCA Now: February 1, 2022: Ivermectin Products are Not Approved by FDA to Prevent or Treat COVID-19
- COCA Now: January 31, 2022: How to Talk with Parents and Caregivers about COVID-19 Vaccination
2021 COCA Now Messages
- December 22, 2021: CDC Encourages Healthcare Providers to Recommend COVID-19 Self-testing Before Holiday Gatherings
- November 2, 2021: CDC Updates Blood Lead Reference Value to 3.5 µg/dL
- September 10, 2021: COCA NOW Clarification COCA Memo: Monoclonal Antibodies Bamlanivimab and Etesevimab May Be Less Effective for Treating Cases of COVID-19 Caused by SARS-CoV-2 Variants
- July 15, 2021: A Snapshot of Work by the COVID-19 Public Health Response
- June 25, 2021: CDC Introduces COVID-19 Viral Testing Online Tool
- March 08, 2021: CDC Infection Prevention and Control Guidance for Identifying and Managing Patients with Possible and Confirmed Ebola Virus Disease
- February 17, 2021: MMWR and JAMA Updates: SARS-CoV-2 Variants
- February 12, 2021: New Botulism Treatment Resources for Healthcare Professionals
- January 05, 2021: Strategies for Optimizing PPE Supplies during Shortages
2020 COCA Now Messages
- December 09: Similarities in Symptoms of SARS-CoV-2 Infection and Carbon Monoxide (CO) Poisoning
- November 16: Scientific Brief: Community Use of Cloth Masks to Control Spread of SARS-CoV-2
- November 2: Two MMWR Updates: Pregnant Women and COVID-19
- October 26: COVID-19–Associated Hospitalizations among Health Care Personnel
- August 10: COVID-19 Laboratory Reporting Requirements
- May 7: New YouTube Video with Guidance for Certifying Deaths Due to COVID-19
- February 24: Sign-up to Receive CDC’s New COVID-19 “What’s New” Weekly Update
- Shipping of CDC 2019 Novel Coronavirus Diagnostic Test Kits Begins
- MMWR Updates: Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak; and Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020
2019 COCA Now Messages
- December 20: Updates: Characteristics of Patients Experiencing Rehospitalization or Death after Hospital Discharge in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI); and Interim Guidance for Health Care Professionals Caring for Patients with Suspected EVALI and Reducing the Risk for Rehospitalization and Death Following Hospital Discharge — United States, 2019
- November 15: Evaluation of BronchoalveolarLavage Fluid Samples from Patients with E-cigarette, or Vaping, Product UseAssociated Lung Injury (EVALI)
- November 5: Update: Resources for National Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries
- October 28: Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries
- October 11: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019
- September 9: CDC Releases Two MMWR E-books on Severe Pulmonary Disease Associated with Electronic-Cigarette Use
- August 23: Outbreak of Salmonella Newport Infections with Decreased Susceptibility to Azithromycin Linked to Beef Obtained in theUnited States and Soft Cheese Obtained in Mexico
- July 15: Clinicians: Timing is Key to Rapidly Recognizing andReporting Acute Flaccid Myelitis Cases
- June 12: First Case of Ebola Virus Disease Associated with Outbreak in DRC Diagnosed in Uganda
- May 31: U.S. Measles Cases Still on the Rise: CDC Encourages Parents to Consult with Their Child’s Pediatrician about Measles Vaccine
- May 3: Measles Outbreak Digital Toolkit for Healthcare Providers
- March 4: Ebola: U.S. Healthcare Infection Prevention and Control Considerations
- January 17: CDC’s Antibiotic Resistance (AR) Solutions Initiative
- January 11: CDC Provides First In-Season Estimates of Flu Illnesses, Medical Visits, and Hospitalizations
- January 10 : Surgeon General’s Advisory on E-cigarette Use Among Youth
Page last reviewed: March 7, 2022
Content source: Center for Preparedness and Response (CPR)